Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

IceCure Medical Ltd. (ICCM) had Revenue of $3.29M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$3.29M
Net Income	$-15.32M
Cost of Goods Sold	$1.84M
Gross Profit	$1.45M
Operating Expenses	$18.99M
Operating Income	$-15.70M
Non-Operating Income/Expense	$0.38M
Pre-Tax Income	$-15.32M
Normalized Pre-Tax Income	$-15.32M
Income after Taxes	$-15.32M
Income from Continuous Operations	$-15.32M
Consolidated Net Income/Loss	$-15.32M
Normalized Income after Taxes	$-15.32M
EBIT	$-15.70M
EBITDA	$-15.36M
Weighted-Average Shares Outstanding (Basic)	50.88M
Weighted-Average Shares Outstanding (Diluted)	50.88M
Earnings per Share (EPS) (Basic)	$-0.30
Earnings per Share (EPS) (Diluted)	$-0.30
Balance Sheet Financials
Current Assets	$10.75M
Property, Plant, and Equipment	$1.25M
Long-Term Assets	$1.82M
Total Assets	$12.58M
Current Liabilities	$5.51M
Long-Term Debt	$0.16M
Long-Term Liabilities	$0.16M
Total Liabilities	$5.67M
Common Equity	$6.90M
Tangible Shareholders Equity	$6.90M
Shareholders Equity	$6.90M
Common Shares Outstanding	56.57M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-12.56M
Cash Flow from Investing Activities	$0.45M
Cash Flow from Financial Activities	$9.19M
Beginning Cash	$10.53M
End Cash	$7.56M
Increase/Decrease in Cash	$-2.97M
Stock-Based Compensation	$0.87M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.07
Gross Margin	44.09%
Operating Margin	-476.94%
EBIT Margin	-476.94%
EBITDA Margin	-466.85%
Pre-Tax Profit Margin	-465.45%
Profit Margin	-465.45%
Free Cash Flow	$-12.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.93
Receiveable Turnover	14.89
Days Sales in Receivables	24.51
Return on Equity	-221.97%
Return on Tangible Equity	-221.97%
Return on Assets	-121.80%
Return on Investments	-216.91%
Book Value Per Share	$0.12
Free Cash Flow per Share	$-0.25
Operating Cash Flow per Share	$-0.25

Data from Zacks Investment Research, Inc.